Kumar, S. K., Uno, H., Jacobus, S. J., Wier, S. A. V., Ahmann, G. J., Henderson, K. J., . . . Rajkumar, S. V. (2011). Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone. American Society of Hematology.
استشهاد بنمط شيكاغوKumar, Shaji K., et al. Impact of Gene Expression Profiling-based Risk Stratification in Patients With Myeloma Receiving Initial Therapy With Lenalidomide and Dexamethasone. American Society of Hematology, 2011.
MLA استشهادKumar, Shaji K., et al. Impact of Gene Expression Profiling-based Risk Stratification in Patients With Myeloma Receiving Initial Therapy With Lenalidomide and Dexamethasone. American Society of Hematology, 2011.